Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Revenue		$ 62,629	$ 53,611	$ 185,083	$ 154,729
Cost of revenue		22,220	20,109	71,845	58,002
Gross profit		40,409	33,502	113,238	96,727
Operating expenses:
Sales and marketing		22,312	17,188	65,616	47,685
General and administrative		8,585	8,580	29,714	26,784
Litigation costs and related recoveries:
Professional fees and other defense costs of litigation		6,990	3,327	25,002	11,724
Litigation appeal refund		0	0	(21,285)	0
Insurance recoveries, net		0	(2,962)	(7,583)	(7,113)
Total operating expenses		37,887	26,133	91,464	79,080
Operating income		2,522	7,369	21,774	17,647
Non-operating expenses:
Interest expense		(9,499)	(9,152)	(32,231)	(33,629)
Other debt financing expenses		(48,375)	(2,563)	(58,331)	(14,704)
Loss from change in fair value of redeemable warrants		0	(5,817)	0	(14,067)
Gain (loss) from change in fair value of embedded derivatives		7,800	1,400	1,600	(4,400)
Other income (expense), net		(306)	108	(1,546)	422
Loss before income taxes		(47,858)	(8,655)	(68,734)	(48,731)
Income tax expense		(510)	(385)	(1,573)	(643)
Net loss		(48,368)	(9,040)	(70,307)	(49,374)
Other comprehensive income (loss):
Foreign currency translation gain (loss)		(377)	(17)	(729)	160
Comprehensive loss		(48,745)	(9,057)	(71,036)	(49,214)
Loss applicable to common stockholders (Note 9)		$ (53,070)	$ (9,040)	$ (75,009)	$ (49,374)
Net loss per share:
Net loss per share of Common Stock (basic and diluted):	[1]	$ (0.85)	$ (0.37)	$ (1.24)	$ (2.02)
Weighted average number of shares of Common Stock outstanding:
Weighted average number of shares of Common Stock outstanding: (basic and diluted):	[1]	62,590	24,727	60,565	24,457

[1] See Note 1 for discussion of reverse recapitalization given effect herein.